Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Hormones
Published in: Hormones 4/2015

01-10-2015 | Review

The impact of adipose tissue-derived factors on the hypothalamic-pituitary-gonadal (HPG) axis

Authors: Christos Tsatsanis, Eirini Dermitzaki, Pavlina Avgoustinaki, Niki Malliaraki, Vasilis Mytaras, Andrew N. Margioris, MD

Published in: Hormones | Issue 4/2015

Login to get access
Metadata
Title
The impact of adipose tissue-derived factors on the hypothalamic-pituitary-gonadal (HPG) axis
Authors
Christos Tsatsanis
Eirini Dermitzaki
Pavlina Avgoustinaki
Niki Malliaraki
Vasilis Mytaras
Andrew N. Margioris, MD
Publication date
01-10-2015
Publisher
Springer International Publishing
Published in
Hormones / Issue 4/2015
Print ISSN: 1109-3099
Electronic ISSN: 2520-8721
DOI
https://doi.org/10.14310/horm.2002.1649

Other articles of this Issue 4/2015

Hormones 4/2015 Go to the issue

Research paper

IGF1 deficiency in newly diagnosed Graves’ disease patients

Research paper

Internalizing and externalizing problems in obese children and adolescents: associations with daily salivary Cortisol concentrations

Review

Hypogonadism in young men treated for cancer

Review

Impact of cancer and cancer treatment on male fertility

Review

A short evolutionary history of FSH-stimulated spermatogenesis

Review

Testicular Descent
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits